Navigation Links
Blood Pressure Lowering Effect of Hypertension Treatment Device Further Validated in New Studies
Date:6/16/2008

ted that patients were compliant with the device and that

no adverse side effects were reported.

-- PS33/THU/01 -- Pooled results from two separate studies led by Profs.

Rosenthal and the Erdine study (above), utilizing 24-hour ambulatory

blood pressure monitoring demonstrated that RESPeRATE benefits

uncontrolled-hypertension sufferers. The analysis demonstrated a

clinically significant blood pressure reduction throughout both daytime

and nighttime. RESPeRATE was also found to independently reduce high

values of a risk-associated arterial property (S-D slope/AASI) derived

from the relationship between systolic and diastolic pressures.

-- PS34/MON/08 -- Data analysis led by Dr. Benjamin Gavish, chief

scientific officer, InterCure, Ltd., of a study performed in Italy,

conducted by Prof. Gianfranco Parati, explored, for the first time, the

linear relationships between systolic and diastolic blood pressure from

beat-to-beat measurements. The derived risk-related parameters (S-D

slope and AASI) are acutely influenced by breathing patterns and neck

suction.

-- PS34/MON/18 -- An Israeli study, conducted by Dr. Iddo Ben-Dov and

Prof. Michael Burzstyn from Hadassah Medical Center, and Dr. Benjamin

Gavish, concluded that the ratio of systolic to diastolic blood

pressure variability is shown to be a blood pressure-independent

predictor of mortality, associated with the linear relationship between

systolic and diastolic pressures.

-- PS18/WED/58 -- An Italian, randomized controlled study, led by Prof. G.

Parati from the University of Milan-Bicocca concluded that device-

guided paced breathing at home is feasible and improves prognostically

relevant clinical and instrumental parameters in heart failure

patients. It is recommended as an additiona
'/>"/>

SOURCE InterCure, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
2. NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR
3. Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
4. Phase 3 Results for Alogliptin Demonstrated Significant Blood Sugar Reductions in Monotherapy and Four Add-on Therapy Studies
5. Study Shows Lantus(R) Helped People Living with Type 2 Diabetes Reach the ADAs Recommended Target for Blood Sugar Control
6. AdvanDx Submits Yeast Traffic Light PNA FISH(TM) for FDA 510(k) Clearance for Detection of Candida species in Positive Blood Cultures
7. Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions
8. New Study Linking High Normal Blood Pressure to Significant Cardiovascular Risk
9. Naturally Occurring Compounds in Cocoa Tied to Blood Flow Improvements for Adults With Type 2 Diabetes
10. New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nations Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
11. Pharmacopeias First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015  Pharmaceutic Labs ... Facility" under section 503B of the FDA,s Drug ... title, the company is subject to Current Good ... bulk medications according to the highest standards of ... Part 211. To continuously comply with FDA regulations ...
(Date:5/28/2015)... 2015 The global departmental PACS market ... , Europe , Asia ... departmental PACS market is expected to reach $3,807.4 million by ... Browse through the TOC of global departmental PACS ... segments, with help of various tables and figures. ...
(Date:5/28/2015)... , May 28, 2015  Janssen Pharmaceuticals, Inc. (Janssen) ... initiation of CALLISTO, a new comprehensive clinical research program ... active cancer. The studies are evaluating the medicine for ... patients with a wide range of cancer types. ... venous thromboembolism (VTE), which is a blood clot in ...
Breaking Medicine Technology:Departmental PACS Market is Expected to Reach $3,807.4 Billion by 2019, at a CAGR of 10.0% From 2014 to 2019 2Departmental PACS Market is Expected to Reach $3,807.4 Billion by 2019, at a CAGR of 10.0% From 2014 to 2019 3New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 2New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 3New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 4New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 5New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 6New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 7New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 8New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 9New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 10New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 11New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 12
(Date:5/28/2015)... May 28, 2015 Medelis, Inc., a ... joined the company in the role of president. , “ ... in the CRO industry,” said Larry Flanagan, Medelis’ CEO and ... company through our next phase of growth.” , Taaffe ... growth from nine employees to over 4,500 employees, achieving 12 ...
(Date:5/28/2015)... May 28, 2015 Altima Technologies, ... Device Library for documenting and diagramming data center ... for the following product lines: , Manufacturer ... 5500, Chatsworth Products N-Series TeraFrame Cabinet, Middle Atlantic ... Eclipse, Fore Systems ForeRunner, Marantz America MM Series, ...
(Date:5/28/2015)... 2015 Nidra Herbal Sleep Supplement features a ... body. A non-addictive supplement, Nidra Herbal Sleep Supplement is more ... will leave users with a real sense of wellbeing the ... Ayurveda, which translates as the “Science or Knowledge of Life”, ... and is a holistic system of knowledge which combines contemplation, ...
(Date:5/28/2015)... ZH Healthcare (ZH), a leading provider of Health ... the Electronic Health Solution, on the Amazon AWS platform ... all AWS users worldwide. , ZH Healthcare is ... Freemium, SaaS, Electronic Health Solution (EHS). BlueEHS offers ... practice management system (PMS), e-Rx, lab interfaces, a telemedicine-enabled ...
(Date:5/28/2015)... The connected car is gaining more ... new vehicles have some iteration of a connected offering ... motor insurance companies as the data collected can be ... usage-based insurance (UBI). This is the primary reason that ... Europe 2015 Conference & Exhibition. , Andrew Pym, ...
Breaking Medicine News(10 mins):Health News:Bill Taaffe, Former President and CEO of ICON Clinical Research-US, Joins Medelis, a Specialty Oncology CRO, in the Role of President 2Health News:NetZoom™ Visio® Stencil Library Updates for EMC, Cisco, and Chatsworth Products 2Health News:Ayurveda Herba Corp’s Revolutionary Herbal Sleep Supplement is Now Available from Amazon.com 2Health News:BlueEHS, the Electronic Health Solution, now available on Amazon AWS Market place 2Health News:BlueEHS, the Electronic Health Solution, now available on Amazon AWS Market place 3Health News:TU-Automotive: North America’s Leading Insurers Head to Chicago as Connected Car Motor Insurance Shifts up a Gear 2Health News:TU-Automotive: North America’s Leading Insurers Head to Chicago as Connected Car Motor Insurance Shifts up a Gear 3
... soon become part of the Indian government's efforts to reach ... HIV/AIDS and promote the use of condoms.// ,Where ... the idea is to reach out through the soft drinks ... estimated at over one million outlets across the country. ...
... form of cancer and nearly one out of every three cancers ... the more alarming is that 73% of people with fair skin ... they still get sunburnt despite almost two thirds worrying it could ... is the cause of nearly all types of skin cancer occurring ...
... interest in eating during old age is the thing of ... which will help older people eat nutritious food and take ... at the institute advise that High fibre in the form ... fight diabetes, heart disease and diverticulosis. Folic acid (400 micrograms ...
... a dietary supplement used in treating obesity and people ... weight loss. The researcher that had systematically reviewed the ... in the latest issue of The Cochrane Library.// ... controlled trials that included 1,131 overweight or obese adults. ...
... can mean much athletic activity that is bad for ... quite a common cause of hospitalization for young adults.// ... Sports Medicine for Coaches Fall Sports Safety Seminar, researchers ... York City’s Hospital for Special Surgery, had said it ...
... South India wake up to the lovely smell of homemade ... coffee lovers now, with firm evidence from recent research. // ... and has been found to contain substances called as anti-oxidants, ... have been linked to a number of potential health benefits, ...
Cached Medicine News:Health News:All Play Is No Good For Health 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: